Key points are not available for this paper at this time.
., implant surface modification with nanoreactors and GUVs for localized production of bactericidal agents in the presence of bacterial growth.
Potter et al. (Tue,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: